Bioprinting of Adipose Tissue Graft with Enhanced Neo‐Vessel Formation in Vivo
Advanced Healthcare Materials · 2025-08 · 14 (21)
DOI: 10.1002/adhm.202500627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 12.06.2025. Verfasst von Hanan Jamal Mohamed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, 50, UNIST-gil, Ulju-gun, Ulsan, 44919, South Korea. Hauptthemen laut MEDLINE: Adipose Tissue, Bioprinting, Neovascularization, Physiologic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Research Foundation of Korea, Nano & Material Technology Development Program.
Abstract (Originalsprache)
Adipose tissue (AT) grafts are widely used in clinical procedures including soft‐tissue augmentation and post‐trauma reconstruction. However, the slow vascularization of conventional AT grafts poses a challenge to their in vivo preservation. To address this challenge, an innovative AT graft is engineered using adipose‐derived stem cell (ADSC) spheroids to enhance blood vessel infiltration. A polycaprolactone (PCL) framework containing precisely positioned ADSC spheroids is 3D bioprinted, and mechanically dissociated fat tissue is loaded into the framework to produce AT grafts. The spheroid diameter and pattern are optimized to significantly enhance the secretion of angiogenic factors from ADSCs in vivo. During an eight‐week in vivo experiment, the bioprinted and transplanted AT grafts demonstrated an impressive 8 fold increase in neo‐vessel formation compared to those in conventional grafts. This heightened neovascularization is directly correlated with a substantial improvement in transplanted AT survival and a 70% reduction in fibrous tissue formation. These findings underscore the pivotal role of ADSC spheroid‐mediated paracrine signaling in facilitating robust integration with the host vascular system. The novel approach significantly enhanced the long‐term viability and preservation of AT grafts by promoting blood vessel infiltration, paving the way for the development of highly vascularized AT grafts for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, 50, UNIST-gil, Ulju-gun, Ulsan, 44919, South Korea.
- Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, 27101, USA.
- Department of Bioengineering, Stanford University, Stanford, CA, 94305, USA.
ORCID-Profile: Hanan Jamal Mohamed, Wonwoo Jeong, Jeonghyun Son, Hyun-Wook Kang
Förderung
- National Research Foundation of Korea
- Nano & Material Technology Development Program
Zitieren
APA
Mohamed, H. J., Jeong, W., Son, J., & Kang, H. W. (2025). Bioprinting of Adipose Tissue Graft with Enhanced Neo‐Vessel Formation in Vivo. Advanced Healthcare Materials, 14(21). https://doi.org/10.1002/adhm.202500627
Vancouver
Mohamed HJ, Jeong W, Son J, Kang HW. Bioprinting of Adipose Tissue Graft with Enhanced Neo‐Vessel Formation in Vivo. Advanced Healthcare Materials. 2025;14(21). doi:10.1002/adhm.202500627
BibTeX
@article{Mohamed2025,
author = {Mohamed, Hanan Jamal and Jeong, Wonwoo and Son, Jeonghyun and Kang, Hyun-Wook},
title = {Bioprinting of Adipose Tissue Graft with Enhanced Neo‐Vessel Formation in Vivo},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {21},
doi = {10.1002/adhm.202500627}
}
EUVIMED